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Prof. Bradding and Dr. Brightling have made several remarks
concerning our report on mast cell numbers in the airway
smooth muscle.1 With respect to their methodological
concerns we would like to respond as follows. First, we
regret that in the Materials and methods section, at the end
of the paragraph on ‘‘bronchoscopy and processing’’, an
(essential) sentence is lacking, just before the last sen-
tence. The sentence to be added is (separately sent to the
editor as ‘‘corrigendum’’): ‘‘Mast cells within and directly in
juxtaposition to smooth muscle were counted’’. We regret
this omission, as this clearly has led to invalid interpreta-
tions. The reason we decided to count mast cells not only
within but also in direct contact with the smooth muscle is
that we wanted to take into account all likely mast cell
effects on smooth muscle that could supposedly affect the
level of hyperresponsiveness. We realise that we should
have made that more clearly in the text.
Further, in addition we actually also did count mast cells
within the muscle area separately, with median (range) of
18 (0–53) for asthma biopsies and 17 (0–46) for controls.
These numbers are in the same range as the other studies:
some report lower,2 some higher3–5 numbers. Such differ-
ences are likely explained by differences in technique
(frozen vs. paraffin vs. plastic-embedded sections) as
discussed by Amin et al.5 Nevertheless, when we performed
statistical analysis on mast cell numbers within airway
smooth muscle only, this led to the same results between
the groups as we reported (no differences; see Table 1). We
agree that our findings are different from several other
reports, and therefore we have discussed these differences.
However, we mainly discussed and pointed out the relation
of mast cell numbers to AMP responsiveness. Although we
agree that the indicated other studies are of importancecell density within airway smooth muscle.
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2007.01.005(2 of these of the same group),3,4 these studies did either
not have a primary focus on biopsy findings3,4 or did not
include hyperresponsiveness.3–5
Our colleagues were mistaken in their suggestion that we
only measured two random high power fields. As clearly
indicated in the Materials and methods section (third page,
first part), we counted all mast cells in two random (whole!)
separate sections of a biopsy. The interval between sections
was 80 mm, which prevents counting the same cells twice.
Further, we also described that we evaluated per subject a
mean area of 0.59mm2 smooth muscle per subject, which at
least equals the measured area in the study of Brightling et
al.2 So this really is similar to the advice to count in- and
around the entire airway smooth muscle bundle in a section
(in fact we even used two separate sections per biopsy).
So we hope we clarified the issues raised. We believe our
results are not contradictory to those of others but in fact an
addition to the field, demonstrating that asthma is a
heterogeneous disease, in this particular report demonstrat-
ing that a difference in bronchial hyperresponsiveness to
adenosine-5-monophosphate is not necessarily dependent
on differences in mast cell numbers inside and juxtaposed to
airway smooth muscle.
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